Solsten Diagnostics International ApS offers strategic partners and prospective investors a wide range of opportunities


Expand and/or preserve existing market share for point-of-care testing (POCT) in a fast-growing market by partnering with us or licensing the AptaSystem® technology. 

The simple user interface and quick response time makes the AptaSystem® particularly suitable platform for general practitioners and primary care units requesting rapid and local clinical decision making. 

Contact us about first-mover opportunities


  • New technology with a wide product span The AptaSystem® technology is not limited to diagnostic use in humans and animals, but is also applicable for analysis of drug metabolites, food and feed safety, and environmental factors.  
  • Plannable and risk-controlled product development The AptaSystem® is based on a platform technology, which allows development of new applications ready for validation within a few months. Thus, it is possible to quickly meet acute market requirements and to bring new products to the market.
  • Production scalability The AptaSystem® has been developed and is produced in-house by a production facility, which is easily scalable. 

Contact us about our production facilities